Skip to main content

Table 1 In vitro antimicrobial susceptibilities of the strain, and interpretation according to Comité d’Antibiogramme de la Société Française de Microbiologie 2013 recommendations, using Pseudomonas aeruginosa ATCC 27853 and Escherichia coli ATCC 25922 as quality control

From: Chryseobacterium indologenes in a woman with acute leukemia in Senegal: a case report

Antibiotics

MIC (μg/mL)

IZD (mm)

Breakpoint (S)

Categorization

μg/mL

mm

Ampicillin

≥256

0

≤16

≥22

Resistant

Piperacillin

16

20

≤16

≥18

Susceptible

Ticarcillin

≥256

0

≤16

≥22

Resistant

Temocillin

≥256

0

≤16

≥22

Resistant

Cephalothin

≥256

0

≤16

≥22

Resistant

Cefuroxime

≥256

0

≤16

≥22

Resistant

Cefotaxime

32

8

≤16

≥22

Resistant

Ceftazidime

4

25

≤08

≥19

Susceptible

Ceftriaxone

32

8

≤16

≥22

Resistant

Cefepime

4

28

≤08

≥19

Susceptible

Cefotetan

≥32

6

≤16

≥22

Resistant

Imipenem

≥32

6

≤04

≥22

Resistant

Meropenem

32

6

≤02

≥22

Resistant

Ertapenem

≥32

6

≤02

≥22

Resistant

Aztreonam

≥32

8

≤01

≥27

Resistant

Trimethoprim-sulfamethoxazole

≤0.25

22

≤2

≥16

Susceptible

Nalidixic acid

≤2

28

≤08

≥20

Susceptible

Gentamicin

ND

4

ND

≥16

Resistant

Amikacin

ND

0

ND

≥17

Resistant

Tobramycin

ND

0

ND

≥16

Resistant

Colistin

ND

0

ND

Resistant

  1. Abbreviations: IZD, inhibition zone diameter; MIC, minimum inhibitory concentration. ‘ND’, Not Determined; ‘–’ Colistin breakpoint not given. S, sensitivity.